首页> 外文期刊>International ophthalmology clinics >Controversy in the Management of Retinal Venous Occlusive Disease
【24h】

Controversy in the Management of Retinal Venous Occlusive Disease

机译:视网膜静脉阻塞性疾病管理中的争议

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Retinal venous occlusive disease is second only to diabetic retinopathy as a cause of retinal vascular disease, The occlusion of a branch retinal vein may produce a branch retinal vein occlusion (BRVO), and the occlusion of the central retinal vein may result in a central retinal vein occlusion (CRVO). The term hemiretinal vein occlusion (HRVO) describes those eyes in which the superior or inferior retinal venous vasculature has been occluded, The incidence of retinal vein occlusions in population-based studies varies from 2 per 1000 to 8 per 1000 persons and increases with age.
机译:视网膜静脉阻塞性疾病是仅次于糖尿病性视网膜病变的视网膜血管疾病的原因。视网膜分支静脉的阻塞可能会导致视网膜分支静脉阻塞(BRVO),而视网膜中央静脉的阻塞可能会导致视网膜中央静脉阻塞(CRVO)。半视网膜静脉阻塞(HRVO)一词描述的是已经阻塞了视网膜上或下静脉血管的那些眼睛。基于人群的研究中,视网膜静脉阻塞的发生率从每千人2次到每千人8次不等,并且随着年龄的增长而增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号